/PRNewswire/ Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials.
According to the media report there is a high risk that these entities may require unbudgeted subventions during fiscal year 2024/25. Despite over 11 million dollars being allocated in supplementaries for these entities at the close of the last financial year. The cancelled plan for the House to meet on a Saturday to vote additional…